These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 19319690)

  • 81. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.
    Annaert P; Van Gelder J; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
    Pharm Res; 1998 Aug; 15(8):1168-73. PubMed ID: 9706045
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
    Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
    Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
    Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
    Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells.
    Hirayama C; Watanabe H; Nakashima R; Nanbu T; Hamada A; Kuniyasu A; Nakayama H; Kawaguchi T; Saito H
    Pharm Res; 2008 Apr; 25(4):827-35. PubMed ID: 17934801
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Evaluation of Drug Transport in MDCKII-Wild Type, MDCKII-MDR1, MDCKII-BCRP and Caco-2 Cell Lines.
    Mukkavilli R; Jadhav G; Vangala S
    Curr Pharm Biotechnol; 2017; 18(14):1151-1158. PubMed ID: 29521222
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
    Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
    J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells.
    Yue GG; Cheng SW; Yu H; Xu ZS; Lee JK; Hon PM; Lee MY; Kennelly EJ; Deng G; Yeung SK; Cassileth BR; Fung KP; Leung PC; Lau CB
    J Med Food; 2012 Mar; 15(3):242-52. PubMed ID: 22181075
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Investigation of the Uptake and Transport of Two Novel Camptothecin Derivatives in Caco-2 Cell Monolayers.
    Wang Y; Zhang X; Zhuang W; Yu Y; Sun X; Wang H; Li F; Li Q
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744795
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
    Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
    Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
    [TBL] [Abstract][Full Text] [Related]  

  • 91. pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.
    Neuhoff S; Ungell AL; Zamora I; Artursson P
    Pharm Res; 2003 Aug; 20(8):1141-8. PubMed ID: 12948010
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps.
    Walle UK; Walle T
    Carcinogenesis; 1999 Nov; 20(11):2153-7. PubMed ID: 10545419
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cotransport of macrolide and fluoroquinolones, a beneficial interaction reversing P-glycoprotein efflux.
    Sikri V; Pal D; Jain R; Kalyani D; Mitra AK
    Am J Ther; 2004; 11(6):433-42. PubMed ID: 15543082
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
    Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
    Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
    [TBL] [Abstract][Full Text] [Related]  

  • 95. In Vitro and In Situ Characterization of the Intestinal Absorption of Capilliposide B and Capilliposide C from
    Zhang X; Cheng X; Wu Y; Feng D; Qian Y; Chen L; Yang B; Gu M
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30925820
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters.
    Te Brake LH; Russel FG; van den Heuvel JJ; de Knegt GJ; de Steenwinkel JE; Burger DM; Aarnoutse RE; Koenderink JB
    Tuberculosis (Edinb); 2016 Jan; 96():150-7. PubMed ID: 26682943
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Renal Excretion of Dabigatran: The Potential Role of Multidrug and Toxin Extrusion (MATE) Proteins.
    Shen H; Yao M; Sinz M; Marathe P; Rodrigues AD; Zhu M
    Mol Pharm; 2019 Sep; 16(9):4065-4076. PubMed ID: 31335150
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Reversible inhibition of efflux transporters by hydrogel microdevices.
    Levy ES; Samy KE; Lamson NG; Whitehead KA; Kroetz DL; Desai TA
    Eur J Pharm Biopharm; 2019 Dec; 145():76-84. PubMed ID: 31639417
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Prandial state and biological sex modulate clinically relevant efflux transporters to different extents in Wistar and Sprague Dawley rats.
    Gavins FKH; Dou L; Qin Y; Madla CM; Murdan S; Basit AW; Mai Y; Orlu M
    Biomed Pharmacother; 2023 Apr; 160():114329. PubMed ID: 36731343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.